Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

HPTLC Approach for Simultaneous Quantification of Valsartan and Sacubitril in Bulk and Tablet Formulations

Breadcrumb

  • Home
  • HPTLC Approach for Simultaneous Quantification of Valsartan and Sacubitril in Bulk and Tablet Formulations

Bhupendra L Deore 1, Amod. S Patil 2, Bhushan J Mali 3, *, Swapnil Patil 4 and Sanket Ratnaparkhi 4

1 Department of Quality Assurance, DCS’s A. R. A. College of Pharmacy, Nagaon, Dhule, MS India.
2 Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Karwand Naka, Shirpur, Dist. Dhule -425 405, India.
3 Department of Pharmaceutical Chemistry, Gangamai College of Pharmacy, Nagaon, Dhule, MS India.
4 Department of Quality Assurance, R. C. Patel Institute of Pharmacy, Shirpur, Dist. Dhule MS India
 
Research Article
World Journal of Advanced Research and Reviews, 2024, 23(03), 3110-3119
Article DOI: 10.30574/wjarr.2024.23.3.3026
DOI url: https://doi.org/10.30574/wjarr.2024.23.3.3026
 
Received on 21 August 2024; revised on 28 September 2024; accepted on 30 September 2024
 
The article introduces an inventive, eco-friendly, simple, consistent and reproducible NP-TLC-Densitometry approach to simultaneous pharmaceutical estimation of Valsartan and Sacubitril in bulk and tablet matrix. Valsartan and Sacubitril is a combination of two medications used to treat high blood pressure (hypertension). This combination is used when a single drug is not enough to control blood pressure. The determination was performed by employing densitometric estimation using ultraviolet exposure at 252 nm. The separation was achieved on (10 × 10 cm) aluminium backed silica gel 60-F254 as stationary phase. Optimized mobile phase was dichloroethane: methanol: triethylamine (4.2:0.4:0.4 v/v/v). Quantitation was conducted over a concentration range of 260 - 1560 ng/band of valsartan and 240 - 1440 ng/band of sacubitril. The compact and well-resolved bands for both drugs in standard and samples were obtained at a retention factor (Rf) value of 0.57 ± 0.02 and 0.42 ± 0.02 for valsartan and sacubitril respectively. As per International Council for Harmonization the established method was successfully validated to various parameters like accuracy, precision, sensitivity, specificity, robustness and shows the satisfactory results for all parameters. The recognized method is simple, accurate, precise, robust, sensitive and economical in nature. This method can be used for quality control of Valsartan and Sacubitril in bulk and in combined dosage form.
 
Valsartan; Sacubitril; HPTLC; ICH
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2024-3026.pdf

Preview Article PDF

Bhupendra L Deore, Amod. S Patil, Bhushan J Mali, Swapnil Patil and Sanket Ratnaparkhi. HPTLC Approach for Simultaneous Quantification of Valsartan and Sacubitril in Bulk and Tablet Formulations. World Journal of Advanced Research and Reviews, 2024, 23(3), 3110-3119. Article DOI: https://doi.org/10.30574/wjarr.2024.23.3.3026

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution